Do you have a lot to say about the GMP production of your lentiviral vector for clinical trials? CAR-TCR Summit Series Europe, 25-27 Feb 2025, London

We’d love to hear it.

Process development, process scalability, and regulatory compliance are critical for advancing CAR-T /NK and TCR-T / NK therapies. As specialists in GMP retroviral and lentiviral vector manufacturing, Team ViroCell can help you navigate these challenges efficiently.

Let’s discuss how our platform approach accelerates timelines and de-risks manufacturing.

25th-27th February
CAR-TCR Summit Series Europe – London
Booth 5

Meet our CSO Farzin Farzaneh, PhD; Principal Scientist, Innovation, Glenda Dickson, PhD, and Sr. Director, Business Development, Makis Sigalas, PhD, at Booth 5, book a meeting on the partnering app or email Makis at MSigalas@virocell.com

#CARTCRSummit #CellTherapy #GeneTherapy #AdvancedTherapies #BiotechInnovation #CGT #CARTCR #CARTCellTherapy #TCRTherapy #Immunotherapy #CancerResearch